TITLE

Etoricoxib was noninferior to diclofenac for cardiovascular outcomes in osteoarthritis and rheumatoid arthitis

PUB. DATE
March 2007
SOURCE
ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p44
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study which states that etoricoxib was noninferior to diclofenac for cardiovascular outcomes in osteoarthritis and rheumatoid arthitis. In the study, 34,701 patients who had osteoarthritis of the knee, hip, hand, or spine or rheumatoid arthritis that met 4 of 7 of the American Rheumatism Association 1987 revised criteria took part. In patients with osteoarthritis or rheumatoid arthritis, etoricoxib was noninferior to diclofenac for cardiovascular outcomes.
ACCESSION #
24685681

 

Related Articles

  • COMMENTARY: Etoricoxib was noninferior to diclofenac for cardiovascular outcomes in osteoarthritis and rheumatoid arthitis. Denman, Michael // ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p44 

    The article presents the comments of the author about a study which states that etoricoxib was noninferior to diclofenac for cardiovascular (CV) outcomes in osteoarthritis and rheumatoid arthitis. The efficacy and incidence of adverse CV and gastrointestinal events were oberved in patients...

  • Arthritis combination protects against NSAID-induced ulcers.  // Modern Medicine;Feb98, Vol. 66 Issue 2, p54 

    Reports on the approval of diclofenac sodium/misoprostol by the US Food & Drug Administration for the relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis for patients at risk of developing non-steroidal inflammatory drug-induced ulcers. Composition of the medication;...

  • American Journal of Cardiology: Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that according to a study by the Mayo Clinic in Rochester, New York, risk assessment tools commonly used by physicians for heart diseases often underestimate the danger of cardiovascular diseases involved in the rheumatoid arthritis patients.

  • PERIPHERAL VASCULAR CIRCULATION IN PATIENTS WITH RHEUMATOID ARTHRITIS INFLUENCE OF PAPAVERINE. Batterman, Robert C.; Jensen, Gary; Jensen, Lynette // Angiology;Oct1970, Vol. 21 Issue 9, p612 

    (1) Utilizing the method of plethysmography without venous occlusion and by determination of the pulse area by computer analysis, the circulatory status of patients with rheumatoid arthritis was found decreased by statistical standards (p < .001) as compared with patients with osteoarthritis and...

  • RESEARCH BRIEFS.  // GP: General Practitioner;3/21/2008, p6 

    The article offers news briefs related to medical research. The protein Robo4 found in blood vessels can prevent the two leading causes of blindness. Young children have greater risk on inflammatory markers when exposed to secondhand smoke. The treatments used for rheumatoid arthritis (RA) can...

  • Etoricoxib: upper GI events less common than with diclofenac.  // Reactions Weekly;2/17/2007, Issue 1139, p4 

    The article discusses research on the association of the use of etoricoxib to treat osteoarthritis and rheumatoid arthritis with incidence of upper gastrointestinal (GI) clinical events. It references a study by L. Laine and colleagues published in the February 10, 2007 issue of "Lancet."...

  • Pathomorphologic Alterations Predict Presence or Absence of Hip Osteoarthrosis. Timo Ecker // Clinical Orthopaedics & Related Research;Dec2007, Vol. 465 Issue 1, p46 

    Abnormal morphology of the hip has been associated with primary osteoarthrosis. We evaluated the morphology of 464 consecutive hips contralateral to hips treated by THA. We excluded all hips with known diagnoses leading to secondary osteoarthritis and all hips with advanced arthrosis to...

  • Hydroxychloroquine is Associated with Less Diabetes in RA.  // Clinical Oncology Alert;Sep2007 Supplement, Vol. 12 Issue 9, p17 

    The article discusses research being done on the incidence of new onset diabetes in rheumatoid arthritis patients treated with hydroxychloroquine (HCQ). It references a study by M. C. M. Wasko et al published in the 2007 issue of the "Journal of American Medical Association." Longer HCQ use was...

  • RA bone loss.  // GP: General Practitioner;5/26/2006, p14 

    The article reports on a British medical study conducted on 74 patients with undifferentiated hand arthritis. The study showed that hand bone loss over 12 months was five to eight times greater in patients who were diagnosed with rheumatoid arthritis, than in those with other inflammatory joint...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics